Point-of-care technologies in heart, lung, blood and sleep disorders from the Center for Advancing Point-of-Care Technologies
- PMID: 32582870
- PMCID: PMC7314358
- DOI: 10.1016/j.cobme.2019.08.011
Point-of-care technologies in heart, lung, blood and sleep disorders from the Center for Advancing Point-of-Care Technologies
Abstract
Recent advancements in point-of-care technologies have transformed care for patients with heart, lung, blood, and sleep disorders by providing rapid, cost-effective, and accessible solutions to challenges in the detection and management of many health conditions. However, major barriers exist throughout the technology development process that inhibit the actualization of many promising and potentially successful ideas. The Center for Advancing Point of Care Technologies has established a system for supporting further innovation in this field and bridging the gap between initial idea conception and implementation. We highlight current and emerging point-of-care technologies throughout the development spectrum and emphasize the need for a needs-driven model of health technology development that involve appropriate stakeholders in the process.
Keywords: Cardiovascular; Chronic disease; Point-of-care; Technology; mHealth.
Conflict of interest statement
Conflict of interest statement McManus receives sponsored research support from Bristol-Myers Squibb, Pfizer, Biotronik, Boehringer Ingelheim, and has consulted for Bristol-Myers Squibb, Pfizer, Samsung Electronics, FlexCon, and has inventor equity in Mobile Sense Technologies, LLC.
References
-
- Lin L, Bessette A. Redesigned Apple Watch Series 4 revolutionizes communication, fitness and health. Apple Newsroom. https://www.apple.com/newsroom/2018/09/redesigned-apple-watch-series-4-r.... (Archived by WebCite® at http://www.webcitation.org/76M5J1ttT). Accessed February 21, 2019.
-
- Raghavan P: 510(k) premarket notification for KardiaMobile 6L (K183319). May 2019. https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpmn/pmn.cfm?ID=K183319. (Accessed 8 June 2019).
-
- Zuckerman B: 510(k) premarket notification for wrist blood pressure monitor model BP4350 (21CFR870.1130). November 2018. https://www.accessdata.fda.gov/cdrh_docs/pdf18/K182166.pdf. (Accessed 21 June 2019).
Grants and funding
LinkOut - more resources
Full Text Sources
Miscellaneous